Document Detail


New Renin Inhibitor VTP-27999 Alters Renin Immunoreactivity and Does Not Unfold Prorenin.
MedLine Citation:
PMID:  23460288     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Renin inhibitors like aliskiren not only block renin but also bind prorenin, thereby inducing a conformational change (like the change induced by acid) allowing its recognition in a renin-specific assay. Consequently, aliskiren can be used to measure prorenin. VTP-27999 is a new renin inhibitor with an aliskiren-like IC50 and t1/2, and a much higher bioavailability. This study addressed (pro)renin changes during treatment of volunteers with VTP-27999 or aliskiren. Both drugs increased renin immunoreactivity. Treatment of plasma samples from aliskiren-treated subjects with excess aliskiren yielded higher renin immunoreactivity levels, confirming the presence of prorenin. Unexpectedly, this approach did not work in VTP-27999-treated subjects, although an assay detecting the prosegment revealed that their blood still contained prorenin. Subsequent in vitro analysis showed that VTP-27999 increased renin immunoreactivity for a given amount of renin by ≥30% but did not unfold prorenin. Yet, it did bind to acid-activated, intact prorenin and then again increased immunoreactivity in a renin assay. However, no such increase in immunoreactivity was seen when measuring acid-activated prorenin bound to VTP-27999 with a prosegment-directed assay. The VTP-27999-induced rises in renin immunoreactivity could be competitively prevented by aliskiren, and antibody displacement studies revealed a higher affinity of the active site-directed antibodies in the presence of VTP-27999. In conclusion, VTP-27999 increases renin immunoreactivity in renin immunoassays because it affects the affinity of the active site-directed antibody. Combined with its lack of effect on prorenin, these data show that VTP-27999 differs from aliskiren. The clinical relevance of these results needs to be established.
Authors:
Manne Krop; Xifeng Lu; Koen Verdonk; Maarten A D H Schalekamp; Jeanette M G van Gool; Brian M McKeever; Richard Gregg; A H Jan Danser
Related Documents :
24627728 - Abnormal gel flotation in a patient with apperant pneumonia diagnosis: a case report.
24270228 - In vivo antibiotic removal during coupled plasma filtration adsorption: a retrospective...
23390278 - Evaluation of quantification of hiv-1 rna viral load in plasma and dried blood spots by...
22972178 - Gh and cortisol responses following an acute session of respiratory muscle endurance tr...
11490148 - Natural killer activity and thyroid hormone levels in young and elderly persons.
4040848 - The ontogeny of biologically active androgen-binding protein in rat plasma, testis, and...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-3-4
Journal Detail:
Title:  Hypertension     Volume:  -     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-3-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Internal Medicine, Division of Pharmacology and Vascular Medicine, Erasmus MC, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Circulating Angiogenic Factors and Urinary Prolactin as Predictors of Adverse Outcomes in Women With...
Next Document:  Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of plac...